SUMATRIPTAN SUCCINATE INJECTIONS
Top five stocks which were in action on WednesdayThe Sensex briefly touched its crucial psychological level of 21,000 in today's trade. Markets will be closed on Thursday on account of Mah...
Dr Reddy’s Laboratories hits 52-week high on Sumatriptan launch in the USDRL pared some of the gains but was still trading 0.7% higher at Rs 2794.50. It has hit a low of Rs 2785.90 and a 52-week high of Rs 2823 o...
Dr Reddy's launches autoinjector system in USPharma major Dr Reddy's Laboratories (DRL) said it has launched Sumatriptan Injection USP in the US.
- Sun Pharma gets USFDA approval for migraine injectionSun Pharma said it has received the USFDA approval for the launch of its generic Sumatriptan Succinate injections in the American market.
- Strides gets US approval for migraine drugDrug maker Strides Arcolab on Monday said US health regulator Food and Drug Administration has given its nod for sale of Sumatriptan Succin...
Load More- Sun Pharma gets USFDA approval for migraine injection